Interim report January - September 2026 Sweco AB (publ)

Sweco posts record Q3 results with rising margins, strong profit, and major new contracts.

What the company is saying

Sweco is highlighting its strongest third quarter ever, emphasizing a double-digit EBITA margin of 10.3% in a seasonally weak period. The company frames its narrative around robust financial growth, with net sales up 7% to SEK 7,606 million and EBITA up 10% year-on-year after calendar adjustments. Management, led by President and CEO Åsa Bergman and CFO Jan Allde, attributes these gains to a strong billing ratio and higher average fees, particularly in Sweden, Norway, and Finland. Sweco also stresses its active M&A strategy, having completed nine acquisitions year-to-date, and its progress in AI adoption to drive productivity and innovation. The announcement gives prominence to major project wins, including a SEK 500 million framework agreement for high-security facilities in Sweden and a national infrastructure contract in Belgium. The tone is confident, with management asserting that market demand remains solid in key sectors and that the company is well positioned for continued growth.

What the data suggests

The disclosed figures show clear financial improvement across all key metrics. Net sales for Q3 2026 rose to SEK 7,606 million from SEK 7,138 million, a 7% increase, with organic growth at 2% after calendar effects. EBITA for the quarter increased to SEK 786 million from SEK 702 million, and the EBITA margin improved to 10.3% from 9.8%. Profit for the period was SEK 521 million, up from SEK 424 million, and earnings per share rose to SEK 1.44 from SEK 1.18. For the first nine months, net sales reached SEK 24,508 million (up from SEK 23,038 million), EBITA was SEK 2,519 million (up from SEK 2,352 million), and profit totaled SEK 1,713 million (up from SEK 1,563 million). Net debt/EBITDA improved to 0.8x from 0.9x, indicating stronger leverage. The company closed nine acquisitions across four business areas and secured a SEK 500 million framework agreement for high-security facilities in Sweden. Management attributes the margin and profit gains to operational efficiency, strong billing, and higher average fees. The data supports management’s claims of improved performance and market resilience.

Analysis

The announcement's tone is positive but proportionate to the disclosed results. Nearly all key claims are realised and supported by detailed financial data: net sales, EBITA, EBIT, profit, and EPS all show clear year-on-year improvement, with margins rising and leverage improving. The only forward-looking statements are general strategic priorities (AI, organic growth, margin targets), which are not presented as imminent financial drivers. Major operational events—acquisitions and contract awards—are described as completed or awarded, not merely targeted. The SEK 500 million framework agreement is a realised contract, not a speculative pipeline item. There is no evidence of narrative inflation or overstatement; the language matches the scale and immediacy of the results.

Risk flags

• ●Integration risk from nine acquisitions closed year-to-date is material; successful synergy capture and cultural alignment are necessary to sustain margin gains, especially as acquisitions span multiple geographies and business areas.
• ●Sectoral exposure risk remains, as the Danish business saw lower EBITA and net sales due to reduced pharmaceutical sector activity, highlighting vulnerability to end-market fluctuations.
• ●Sustained margin improvement depends on continued strong billing ratios and fee levels; any deterioration in project mix or pricing power could pressure profitability.
• ●Execution risk exists in delivering on large new contracts, such as the SEK 500 million high-security facilities agreement and the Belgian infrastructure framework, where delays or cost overruns could impact margins.
• ●AI and digital innovation are positioned as future growth drivers, but the announcement does not quantify realised financial benefits from these initiatives, making the timeline and scale of impact uncertain.

Bottom line

Sweco delivered record Q3 results, with higher sales, margins, and profit, underpinned by strong operational execution and a robust acquisition pipeline. The company’s financial disclosures are comprehensive, with all key metrics showing year-on-year improvement and leverage ratios strengthening. Major new contracts in Sweden and Belgium provide additional revenue visibility, while the active M&A agenda signals ongoing growth ambitions. Risks include integrating multiple recent acquisitions, exposure to sector-specific downturns, and the need to translate AI and digital investments into tangible financial outcomes. The most important takeaway is Sweco’s demonstrated ability to grow profitably in a challenging market, but sustaining this trajectory will require flawless execution on integration and project delivery.

Announcement summary

(NASDAQ:SWEC) Sweco reported its strongest third quarter results to date, achieving a double-digit EBITA margin in a seasonally challenging quarter. Net sales for July–September 2026 increased to SEK 7,606 million from SEK 7,138 million in the prior year period, representing a 7 per cent increase and 2 per cent organic growth adjusted for calendar effects. EBITA for the quarter rose to SEK 786 million from SEK 702 million, with the EBITA margin improving to 10.3 per cent from 9.8 per cent. EBIT for the quarter increased to SEK 752 million from SEK 643 million, with a margin of 9.9 per cent compared to 9.0 per cent. Profit for the period was SEK 521 million, up from SEK 424 million. Earnings per share for the quarter increased to SEK 1.44 from SEK 1.18, and diluted earnings per share rose to SEK 1.44 from SEK 1.17. For January–September 2026, net sales increased to SEK 24,508 million from SEK 23,038 million. EBITA for the nine-month period was SEK 2,519 million, up from SEK 2,352 million, with a margin of 10.3 per cent compared to 10.2 per cent. EBIT for the period increased to SEK 2,433 million from SEK 2,254 million, with a margin of 9.9 per cent versus 9.8 per cent. Net debt/EBITDA decreased to 0.8x from 0.9x, while net debt increased to SEK 3,160 million from SEK 3,124 million. Profit for the nine-month period was SEK 1,713 million, up from SEK 1,563 million. Earnings per share for the period increased to SEK 4.74 from SEK 4.34, and diluted earnings per share rose to SEK 4.73 from SEK 4.32. The improvement in results was mainly driven by a strong billing ratio and higher average fees. Sweden, Norway, and Finland were the main contributors to EBITA improvement, while Sweco Belgium delivered strong margins and Sweco Netherlands, UK, and Germany & Central Europe continued to improve profits. In Denmark, EBITA and net sales were lower due to reduced activity in the pharmaceutical sector, though margins remained strong. During the quarter, Sweco completed the acquisition of four businesses: STEIN Ingenieure (Germany), Sitowise Sverige AB (Sweden), All Soil Assistance (Belgium), and Technocon (Belgium). In early October, Sweco also completed the acquisition of Stendess in Belgium. In total, nine acquisitions have been closed so far this year across four business areas. In Denmark, Sweco was appointed sole consultant to Aalborg Forsyning for the development of a diversified energy system. In Belgium, Sweco entered a major framework agreement with NMBS/SNCB to supervise and quality-assure infrastructure works at stations nationwide. In Sweden, Sweco was awarded a SEK 500 million framework agreement for high-security facilities for Specialfastigheter. Sweco continues to focus on AI development, internal efficiency, commercial focus, and an active M&A agenda. A webcast and telephone conference regarding the results will be held at 09.00 CET, with President and CEO Åsa Bergman and CFO Jan Allde commenting on the report.

Disagree with this article?